Relationships between the adverse effects of drugs and genetic polymorphism in genes encoding drug metabolizing enzymes.
Miners
John O
JO
Day
Richard O
RO
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001189:Aryl Hydrocarbon Hydroxylases; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D065729:Cytochrome P-450 CYP2C9; D014453:Glucuronosyltransferase; D006801:Humans; D011110:Polymorphism, Genetic
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; C110655:UDP-glucuronosyltransferase, UGT1A6; D014453:Glucuronosyltransferase